Suppr超能文献

蛋白激酶 C-δ在脓毒症中调节血小板活化和血小板-白细胞相互作用中的作用。

Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis.

机构信息

Sol Sherry Thrombosis Research Center, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.

Center for Inflammation, Translational and Clinical Lung Research, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, United States of America.

出版信息

PLoS One. 2018 Apr 4;13(4):e0195379. doi: 10.1371/journal.pone.0195379. eCollection 2018.

Abstract

Sepsis is characterized by an intense systemic inflammatory response activating a cascade of proinflammatory events resulting in leukocyte dysregulation and host tissue damage. The lung is particularly susceptible to systemic inflammation, leading to acute lung injury. Key to inflammation-induced lung damage is the excessive migration of neutrophils across the vascular endothelium. The mechanisms which regulate neutrophil activation and migration in sepsis are not well defined but there is growing evidence that platelets are actively involved and play a key role in microvascular permeability and neutrophil-mediated organ damage. We previously identified PKC-delta (PKCδ) as a critical regulator of the inflammatory response in sepsis and demonstrated PKCδ inhibition was lung protective. However, the role of PKCδ in sepsis-induced platelet activation and platelet-leukocyte interactions is not known. In this study, rats underwent sham surgery or cecal ligation and puncture (CLP) to induce sepsis. Following surgeries, a PKCδ inhibitor (200μg/kg) or vehicle (PBS) was administered intra-tracheally. At 24 hours post-surgeries, lung tissue, BAL fluid, and blood samples were collected. While sepsis caused thrombocytopenia, the remaining circulating platelets were activated as demonstrated by increased p-selectin expression, elevated plasma PF4, and enhanced platelet-leukocyte aggregate formation compared to Sham animals. Platelet activation was associated with increased platelet PKCδ activity. Inhibition of PKCδ attenuated sepsis-induced platelet activation, secretion and aggregate formation. Sepsis-induced thrombocytopenia was also significantly reduced and circulating platelet numbers were similar to sham animals. In the lung, sepsis induced significant influx of platelets and neutrophils and the development of lung injury. Administration of the PKCδ inhibitor decreased platelet and neutrophil influx, and was lung protective. Thus, PKCδ inhibition modulated platelet activity both locally and systemically, decreased neutrophil influx into the lung, and was lung protective. We demonstrate for the first time that PKCδ plays an important role in platelet activation and platelet-neutrophil interaction during sepsis.

摘要

脓毒症的特征是强烈的全身炎症反应,激活一系列促炎事件,导致白细胞失调和宿主组织损伤。肺特别容易受到全身炎症的影响,导致急性肺损伤。炎症引起的肺损伤的关键是中性粒细胞过度穿过血管内皮。调节脓毒症中性粒细胞激活和迁移的机制尚不清楚,但越来越多的证据表明血小板积极参与并在微血管通透性和中性粒细胞介导的器官损伤中发挥关键作用。我们之前确定蛋白激酶 C-δ (PKCδ) 是脓毒症炎症反应的关键调节因子,并证明 PKCδ 抑制具有肺保护作用。然而,PKCδ 在脓毒症诱导的血小板激活和血小板-白细胞相互作用中的作用尚不清楚。在这项研究中,大鼠接受假手术或盲肠结扎和穿刺 (CLP) 以诱导脓毒症。手术后,经气管内给予 PKCδ 抑制剂(200μg/kg)或载体(PBS)。手术后 24 小时,收集肺组织、BAL 液和血液样本。虽然脓毒症导致血小板减少症,但与 sham 动物相比,剩余的循环血小板被激活,表现为 p 选择素表达增加、血浆 PF4 升高以及血小板-白细胞聚集体形成增强。血小板激活与血小板 PKCδ 活性增加有关。PKCδ 抑制减弱了脓毒症诱导的血小板激活、分泌和聚集体形成。脓毒症诱导的血小板减少症也明显减少,循环血小板数量与 sham 动物相似。在肺部,脓毒症引起血小板和中性粒细胞明显涌入,并导致肺损伤。PKCδ 抑制剂的给药减少了血小板和中性粒细胞的涌入,并具有肺保护作用。因此,PKCδ 抑制在局部和全身调节血小板活性,减少中性粒细胞进入肺部,并具有肺保护作用。我们首次证明 PKCδ 在脓毒症期间在血小板激活和血小板-中性粒细胞相互作用中发挥重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8aa7/5884571/26b6851c3ee4/pone.0195379.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验